Convergent effects of mouse Pet-1 deletion and human PET-1 variation on amygdala fear and threat processing

Experimental Neurology

Volumn 250, Issue , 2013, Pages 260-269

  Wellman, Cara L ^a   Camp, Marguerite ^b   Jones, V Morgan ^a   MacPherson, Kathryn P ^b   Ihne, Jessica ^b   Fitzgerald, Paul ^b   Maroun, Mouna ^c   Drabant, Emily ^d   Bogdan, Ryan ^e   Hariri, Ahmad R ^e   Holmes, Andrew ^b  

^a INDIANA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c UNIVERSITY OF HAIFA   (Israel)

^d 23andMe ^*  (United States)

^e DUKE UNIVERSITY   (United States)

Author keywords

Basolateral amygdala; Fear conditioning; FEV; Medial prefrontal cortex; Serotonin

Indexed keywords

SEROTONIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR PET 1; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANXIETY; ARTICLE; BOLD SIGNAL; CELL STRUCTURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DENDRITE; DEPRESSION; EMOTION; FEAR; FEMALE; FOREBRAIN; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE DELETION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMAGE RECONSTRUCTION; LIMBIC CORTEX; LOCOMOTION; MALE; MAZE TEST; MENTAL DISEASE; MOTOR COORDINATION; MOUSE; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; ROTAROD TEST; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES EXTINCTION; STRESS; THREAT; VENTROMEDIAL PREFRONTAL CORTEX;

5-HTT; BASOLATERAL AMYGDALA; BLA; ETHANOL; ETOH; FEAR CONDITIONING; FEV; KNOCKOUT; KO; MEDIAL PREFRONTAL CORTEX; PET-1, FEV; PHEOCHROMOCYTOMA 12 ETS; PL; POSTTRAUMATIC STRESS DISORDER; PRELIMBIC CORTEX; PTSD; SEROTONIN; THE SEROTONIN TRANSPORTER; TPH2; TRYPTOPHAN HYDROXYLASE-2; VENTROMEDIAL PREFRONTAL CORTEX; VMPFC;

AMYGDALA; ANIMALS; ANXIETY DISORDERS; CONDITIONING, CLASSICAL; DENDRITES; DNA-BINDING PROTEINS; EMOTIONS; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84886252741     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.09.025     Document Type: Article

References (74)

1. Amunts K., Kedo O., Kindler M., Pieperhoff P., Mohlberg H., Shah N.J., Habel U., Schneider F., Zilles K. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat. Embryol. 2005, 210:343-352.
2. Anglada-Figueroa D., Quirk G.J. Lesions of the basal amygdala block expression of conditioned fear but not extinction. J. Neurosci. 2005, 25:9680-9685.
3. Ansorge M.S., Hen R., Gingrich J.A. Neurodevelopmental origins of depressive disorders. Curr. Opin. Pharmacol. 2007, 7:8-17.
4. Beaulieu J.M., Zhang X., Rodriguiz R.M., Sotnikova T.D., Cools M.J., Wetsel W.C., Gainetdinov R.R., Caron M.G. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1333-1338.
5. Bogdan R., Williamson D.E., Hariri A.R. Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. Am. J. Psychiatry 2012, 169:515-522.
6. Bortolato M., Chen K., Godar S.C., Chen G., Wu W., Rebrin I., Farrell M.R., Scott A.L., Wellman C.L., Shih J.C. Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology 2011, 36:2674-2688.
7. Boyce-Rustay J.M., Wiedholz L.M., Millstein R.A., Carroll J., Murphy D.L., Daws L.C., Holmes A. Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol. Clin. Exp. Res. 2006, 30:1957-1965.
8. Bradley R., Greene J., Russ E., Dutra L., Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. Am. J. Psychiatr. 2005, 162:214-227.
9. Brown S.M., Peet E., Manuck S.B., Williamson D.E., Dahl R.E., Ferrell R.E., Hariri A.R. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol. Psychiatry 2005, 10:884-888. (805).
10. Browne C.A., Clarke G., Dinan T.G., Cryan J.F. An effective dietary method for chronic tryptophan depletion in two mouse strains illuminates a role for 5-HT in nesting behaviour. Neuropharmacology 2012, 62:1903-1915.
11. Burgos-Robles A., Vidal-Gonzalez I., Quirk G.J. Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. J. Neurosci. 2009, 29:8474-8482.
12. Camp M.C., MacPherson K.P., Lederle L., Graybeal C., Gaburro S., DeBrouse L.M., Ihne J.L., Bravo J.A., O'Connor R.M., Ciocchi S., Wellman C.L., Luthi A., Cryan J.F., Singewald N., Holmes A. Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes. Neuropsychopharmacology 2012, 37:1534-1547.
13. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 2010, 167:509-527.
14. Crusio W.E., Goldowitz D., Holmes A., Wolfer D. Standards for the publication of mouse mutant studies. Genes Brain Behav. 2009, 8:1-4.
15. Dai J.X., Han H.L., Tian M., Cao J., Xiu J.B., Song N.N., Huang Y., Xu T.L., Ding Y.Q., Xu L. Enhanced contextual fear memory in central serotonin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11981-11986.
16. Daws L.C., Montanez S., Munn J.L., Owens W.A., Baganz N.L., Boyce-Rustay J.M., Millstein R.A., Wiedholz L.M., Murphy D.L., Holmes A. Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J. Neurosci. 2006, 26:6431-6438.
17. Deneris E.S. Molecular genetics of mouse serotonin neurons across the lifespan. Neuroscience 2011, 197:17-27.
18. Do C.B., Tung J.Y., Dorfman E., Kiefer A.K., Drabant E.M., Francke U., Mountain J.L., Goldman S.M., Tanner C.M., Langston J.W., Wojcicki A., Eriksson N. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet. 2011, 7:e1002141.
19. Duncan L.E., Keller M.C. A critical review of the first 10years of candidate gene-by-environment interaction research in psychiatry. Am. J. Psychiatr. 2011, 168:1041-1049.
20. Ehrlich I., Humeau Y., Grenier F., Ciocchi S., Herry C., Luthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
21. Ekman P., Friesen W.V. Pictures of Facial Affect 1976, Consulting Psychologists Press, Palo Alto.
22. Eriksson N., Macpherson J.M., Tung J.Y., Hon L.S., Naughton B., Saxonov S., Avey L., Wojcicki A., Pe'er I., Mountain J. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genet. 2010, 6:e1000993.
23. Esaki T., Cook M., Shimoji K., Murphy D.L., Sokoloff L., Holmes A. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5582-5587.
24. Felmingham K.L., Bryant R.A. Gender differences in the maintenance of response to cognitive behavior therapy for posttraumatic stress disorder. J. Consult. Clin. Psychol. 2012, 80:196-200.
25. Fernandez S.P., Gaspar P. Investigating anxiety and depressive-like phenotypes in genetic mouse models of serotonin depletion. Neuropharmacology 2012, 62:144-154.
26. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 1997, American Psychiatric Press, Inc., Washington, D.C.
27. Fisher P.M., Hariri A.R. Linking variability in brain chemistry and circuit function through multimodal human neuroimaging. Genes Brain Behav. 2012, 11:633-642.
28. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
29. Glaser E.M., Van der Loos H. Analysis of thick brain sections by obverse-reverse computer microscopy: application of a new, high clarity Golgi-Nissl stain. J. Neurosci. Methods 1981, 4:117-125.
30. Goldman D., Ducci F. Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. Sci. World J. 2007, 7:124-130.
31. Graybeal C., Feyder M., Schulman E., Saksida L.M., Bussey T.J., Brigman J.L., Holmes A. Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF. Nat. Neurosci. 2011, 14:1507-1509.
32. Hariri A.R. The neurobiology of individual differences in complex behavioral traits. Annu. Rev. Neurosci. 2009, 32:225-247.
33. Hariri A.R. Genetic polymorphisms: a cornerstone of translational biobehavioral research. Sci. Transl. Med. 2010, 2. (18ps16).
34. Hariri A.R., Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 2006, 10:182-191.
35. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
36. Hariri A.R., Gorka A., Hyde L.W., Kimak M., Halder I., Ducci F., Ferrell R.E., Goldman D., Manuck S.B. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol. Psychiatry 2009, 66:9-16.
37. Hart A.B., de Wit H., Palmer A.A. Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology 2013, 38:802-816.
38. Hartley C.A., McKenna M.C., Salman R., Holmes A., Casey B.J., Phelps E.A., Glatt C.E. Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory. Proc Natl Acad Sci U S A. 2012, 109:5493-5498.
39. Hayes A.F. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach 2013, Guilford Press, New York City, NY, USA.
40. Hendricks T.J., Fyodorov D.V., Wegman L.J., Lelutiu N.B., Pehek E.A., Yamamoto B., Silver J., Weeber E.J., Sweatt J.D., Deneris E.S. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
41. Herry C., Ferraguti F., Singewald N., Letzkus J.J., Ehrlich I., Luthi A. Neuronal circuits of fear extinction. Eur. J. Neurosci. 2010, 31:599-612.
42. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci. Biobehav. Rev. 2008, 32:1293-1314.
43. Holmes A., Hariri A.R. The serotonin transporter gene-linked polymorphism and negative emotionality: placing single gene effects in the context of genetic background and environment. Genes Brain Behav. 2003, 2:332-335.
44. Holmes A., Murphy D.L., Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 2003, 54:953-959.
45. Karlsson R.M., Hefner K.R., Sibley D.R., Holmes A. Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization. Psychopharmacology (Berl) 2008, 200:117-127.
46. Kiyasova V., Fernandez S.P., Laine J., Stankovski L., Muzerelle A., Doly S., Gaspar P. A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. J. Neurosci. 2011, 31:2756-2768.
47. Larkman A.U. Dendritic morphology of pyramidal neurones of the visual cortex of the rat: I. Branching patterns. J. Comp. Neurol. 1991, 306:307-319.
48. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
49. Lerch-Haner J.K., Frierson D., Crawford L.K., Beck S.G., Deneris E.S. Serotonergic transcriptional programming determines maternal behavior and offspring survival. Nature Neurosci. 2008, 11:1001-1003.
50. Liu C., Maejima T., Wyler S.C., Casadesus G., Herlitze S., Deneris E.S. Pet-1 is required across different stages of life to regulate serotonergic function. Nat. Neurosci. 2010, 13:1190-1198.
51. Milad M.R., Pitman R.K., Ellis C.B., Gold A.L., Shin L.M., Lasko N.B., Zeidan M.A., Handwerger K., Orr S.P., Rauch S.L. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol. Psychiatry 2009, 66:1075-1082.
52. Millstein R.A., Ralph R.J., Yang R.J., Holmes A. Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains. Genes Brain Behav. 2006, 5:346-354.
53. Mozhui K., Karlsson R.M., Kash T.L., Ihne J., Norcross M., Patel S., Farrell M.R., Hill E.E., Graybeal C., Martin K.P., Camp M., Fitzgerald P.J., Ciobanu D.C., Sprengel R., Mishina M., Wellman C.L., Winder D.G., Williams R.W., Holmes A. Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J. Neurosci. 2010, 30:5357-5367.
54. Muller J.F., Mascagni F., McDonald A.J. Serotonin-immunoreactive axon terminals innervate pyramidal cells and interneurons in the rat basolateral amygdala. J. Comp. Neurol. 2007, 505:314-335.
55. Nietzer S.L., Bonn M., Jansen F., Heiming R.S., Lewejohann L., Sachser N., Asan E.S., Lesch K.P., Schmitt A.G. Serotonin transporter knockout and repeated social defeat stress: impact on neuronal morphology and plasticity in limbic brain areas. Behav. Brain Res. 2011, 220:42-54.
56. Nikolova Y.S., Hariri A.R. Neural responses to threat and reward interact to predict stress-related problem drinking: a novel protective role of the amygdala. Biol. Mood Anxiety Disord. 2012, 2:19.
57. Paulus E.V., Mintz E.M. Developmental disruption of the serotonin system alters circadian rhythms. Physiol. Behav. 2011, 105:257-263.
58. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
59. Porsolt R.D., Bertin A., Jalfre M. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 1978, 51:291-294.
60. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nat. Rev. Neurosci. 2009, 10:423-433.
61. Savelieva K.V., Zhao S., Pogorelov V.M., Rajan I., Yang Q., Cullinan E., Lanthorn T.H. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 2008, 3:e3301.
62. Schaefer T.L., Vorhees C.V., Williams M.T. Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness. Neuroscience 2009, 164:1431-1443.
63. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. (quiz 34-57).
64. Singewald N., Salchner P., Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol. Psychiatry 2003, 53:275-283.
65. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R., Jacobs G.A. Manual for the State-Trait Anxiety Inventory 1983, Consulting Psychologists Press, Palo Alto, CA.
66. Tung J.Y., Do C.B., Hinds D.A., Kiefer A.K., Macpherson J.M., Chowdry A.B., Francke U., Naughton B.T., Mountain J.L., Wojcicki A., Eriksson N. Efficient replication of over 180 genetic associations with self-reported medical data. PLoS ONE 2011, 6:e23473.
67. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15:273-289.
68. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S.L., Quirk G.J. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn. Mem. 2006, 13:728-733.
69. Watson D., Clark L.A., Weber K., Assenheimer J.S., Strauss M.E., McCormick R.A. Testing a tripartite model: II. Exploring the symptom structure of anxiety and depression in student, adult, and patient samples. J. Abnorm. Psychol. 1995, 104:15-25.
70. Wellman C.L., Izquierdo A., Garret J.E., Martin K.P., Carroll J., Millstein R., Lesch K.P., Murphy D.L., Holmes A. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 2007, 27:684-691.
71. Whittle N., Hauschild M., Lubec G., Holmes A., Singewald N. Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction. J. Neurosci. 2010, 30:13586-13596.
72. Wilber A.A., Walker A.G., Southwood C.J., Farrell M.R., Lin G.L., Rebec G.V., Wellman C.L. Chronic stress alters neural activity in medial prefrontal cortex during retrieval of extinction. Neuroscience 2011, 174:115-131.
73. Yang R.J., Mozhui K., Karlsson R.M., Cameron H.A., Williams R.W., Holmes A. Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning. Neuropsychopharmacology 2008, 33:2595-2604.
74. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004, 305:217.